Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Haefliger

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Frontiers in Bioengineering and Biotechnology|October 23, 2024
Assessing the metastatic potential of circulating tumor cells using an organ-on-chip modelKarin F Schmid, Soheila Zeinali, Susanne K Moser, et al.
Geroscience|June 16, 2024
Epigenetic age acceleration is a distinctive trait of epithelioid sarcoma with potential therapeutic implicationsSimon Haefliger, Olga Chervova, Christopher Davies, et al.
Head and Neck Pathology|June 26, 2021
Ossifying Fibroma of Non-odontogenic Origin: A Fibro-osseous Lesion in the Craniofacial Skeleton to be (Re-)consideredDaniel Baumhoer, Simon Haefliger, Baptiste Ameline, et al.
Investigational New Drugs|February 15, 2023
Safety and anti-tumor activity of lisavanbulin administered as 48-hour infusion in patients with ovarian cancer or recurrent glioblastoma: a phase 2a studyMarkus Joerger, Thomas Hundsberger, Simon Haefliger, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|October 6, 2022
Prevalence of Molecular Alterations in a Swiss Cohort of 512 Colorectal Carcinoma Patients by Targeted Next-Generation Sequencing Analysis in Routine DiagnosticsSimon Haefliger, Katharina Marston, Ilaria Alborelli, et al.
The Journal of Pathology|June 14, 2023
Subclassification of epithelioid sarcoma with potential therapeutic impactSimon Haefliger, Olga Chervova, Christopher Davies, et al.
Frontiers in Medicine|November 5, 2019
Danger of Herbal Tea: A Case of Acute Cholestatic Hepatitis Due to <i>Artemisia annua</i> TeaFrancisco Javier Ruperti-Repilado, Simon Haefliger, Sophia Rehm, et al.
Histopathology|December 30, 2022
Genetic and epigenetic analysis of hepatocellular adenomas with atypical morphological featuresSimon Haefliger, Juergen Hench, Colm J O'Rourke, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|February 21, 2020
Molecular Profile of Gastrointestinal Stromal Tumors in Sixty-Eight Patients from a Single Swiss InstitutionSimon Haefliger, Katharina Marston, Darius Juskevicius, et al.
Lung Cancer (Amsterdam, Netherlands)|September 13, 2022
Fibroblast growth factor receptor (FGFR) inhibitor rogaratinib in patients with advanced pretreated squamous-cell non-small cell lung cancer over-expressing FGFR mRNA: The SAKK 19/18 phase II studyAlfredo Addeo, Sacha I Rothschild, Lisa Holer, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Frontiers in Bioengineering and Biotechnology|October 23, 2024
Assessing the metastatic potential of circulating tumor cells using an organ-on-chip modelKarin F Schmid, Soheila Zeinali, Susanne K Moser, et al.
Geroscience|June 16, 2024
Epigenetic age acceleration is a distinctive trait of epithelioid sarcoma with potential therapeutic implicationsSimon Haefliger, Olga Chervova, Christopher Davies, et al.
Head and Neck Pathology|June 26, 2021
Ossifying Fibroma of Non-odontogenic Origin: A Fibro-osseous Lesion in the Craniofacial Skeleton to be (Re-)consideredDaniel Baumhoer, Simon Haefliger, Baptiste Ameline, et al.
Investigational New Drugs|February 15, 2023
Safety and anti-tumor activity of lisavanbulin administered as 48-hour infusion in patients with ovarian cancer or recurrent glioblastoma: a phase 2a studyMarkus Joerger, Thomas Hundsberger, Simon Haefliger, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|October 6, 2022
Prevalence of Molecular Alterations in a Swiss Cohort of 512 Colorectal Carcinoma Patients by Targeted Next-Generation Sequencing Analysis in Routine DiagnosticsSimon Haefliger, Katharina Marston, Ilaria Alborelli, et al.
The Journal of Pathology|June 14, 2023
Subclassification of epithelioid sarcoma with potential therapeutic impactSimon Haefliger, Olga Chervova, Christopher Davies, et al.
Frontiers in Medicine|November 5, 2019
Danger of Herbal Tea: A Case of Acute Cholestatic Hepatitis Due to <i>Artemisia annua</i> TeaFrancisco Javier Ruperti-Repilado, Simon Haefliger, Sophia Rehm, et al.
Histopathology|December 30, 2022
Genetic and epigenetic analysis of hepatocellular adenomas with atypical morphological featuresSimon Haefliger, Juergen Hench, Colm J O'Rourke, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|February 21, 2020
Molecular Profile of Gastrointestinal Stromal Tumors in Sixty-Eight Patients from a Single Swiss InstitutionSimon Haefliger, Katharina Marston, Darius Juskevicius, et al.
Lung Cancer (Amsterdam, Netherlands)|September 13, 2022
Fibroblast growth factor receptor (FGFR) inhibitor rogaratinib in patients with advanced pretreated squamous-cell non-small cell lung cancer over-expressing FGFR mRNA: The SAKK 19/18 phase II studyAlfredo Addeo, Sacha I Rothschild, Lisa Holer, et al.
Pageof 5